Clinical Trials Logo

Optical Coherence Tomography clinical trials

View clinical trials related to Optical Coherence Tomography.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06339021 Not yet recruiting - Clinical trials for ST Elevation Myocardial Infarction

OCT or Angiography Guided De-escalation of DAPT

Start date: April 1, 2024
Phase: Early Phase 1
Study type: Interventional

Optical coherence tomography (OCT) offers a high-resolution intravascular imaging modality to accurately assess vessel and lumen geometry and identify the hallmark of a culprit lesion including plaque disruption and thrombus. In addition, the incorporation of the MLD MAX algorithm into daily practice guides an efficient and easily-memorable workflow for optimized OCT-guided percutaneous coronary intervention (PCI) with drug-eluting stents (DES). Regarding the antithrombotic therapy after revascularization, the 2023 ESC guidelines recommend the P2Y12 receptor inhibitor de-escalation (i.e. switching from ticagrelor to clopidogrel) in ACS patients may be considered as an alternative strategy to the default treatment regimen in order to reduce the risk of bleeding events. Based on the above conclusions, we designed a single-center, prospective, randomized controlled, exploratory study trial to evaluate whether the utility of OCT for guiding PCI with DES followed by antiplatelet de-escalation therapy could further reduce the stent-induced intimal hyperplasia of STEMI patients after stent implantation.

NCT ID: NCT06273722 Not yet recruiting - Clinical trials for Basal Cell Carcinoma

D-OCT for Detection and Subtyping of BCC: a Diagnostic Cohort Study

Start date: April 1, 2024
Phase:
Study type: Observational

The current gold standard for diagnosing basal cell carcinoma (BCC) is the histopathological examination of biopsy specimen. However, non-invasive imaging modalities such as optical coherence tomography (OCT) may replace biopsy if BCC presence and its subtype can be established with high confidence. Subtype differentiation is crucial; while superficial BCCs (sBCC) can be treated topically, nodular (nBCC) and infiltrative BCCs (iBCC) require excision. Dynamic OCT (D-OCT) is a functionality integrated within the OCT device, enabling the visualization of vascular structures through speckle variance. Descriptive studies have unveiled vascular shapes and patterns associated with BCC and its respective subtypes. These findings suggest that D-OCT could contribute to the accuracy of BCC detection and subtyping. Yet comparative clinical studies between OCT and D-OCT are lacking. In the proposed diagnostic cohort study, we aim to assess whether D-OCT assessment is superior to OCT in terms of accuracy for BCC detection and subtyping.

NCT ID: NCT06040073 Not yet recruiting - Clinical trials for Optical Coherence Tomography

Natural History of Coronary Atherosclerosis

NASCENT
Start date: October 1, 2023
Phase:
Study type: Observational

The present study sought to explore the predictive value of radial wall strain (RWS, derived solely from angiograms) for coronary artery lesion progression compared with lesion vulnerability assessed by optical coherence tomography (OCT). The lesion progression at 1 year was defined as an increase of ≥20% in diameter stenosis based on quantitative coronary angiography (QCA) evaluation.

NCT ID: NCT03390205 Not yet recruiting - Clinical trials for Optical Coherence Tomography

OCT Angiography in Vitreo and Chorioretinal Pathologies

Start date: February 2018
Phase: N/A
Study type: Observational

In many diseases of the vitreo and chorioretinal complex, perfusion changes have a diagnostic, prognostic or causative role. The visualisation of perfusion was limited to invasive techniques, which were only to depict vasculature in one plane. Optical coherence tomography is able to visualise and quantify eye perfusion layer-specific and non-invasive.

NCT ID: NCT01557205 Not yet recruiting - Clinical trials for Optical Coherence Tomography

Research and System Development on Functional 3D Optical Tomography for Skin Cell Imaging

Start date: March 2012
Phase: N/A
Study type: Observational

The investigators will obtain human skin specimen (sized approximately 1 cm x 1 cm) for dermatological surgical patients in National Taiwan University Hospital, after informed consent was obtained. Human skin keratinocytes, fibroblasts, and melanocytes will be cultured from the human skin specimen. The three dimensional images of these cultured cells will be observed by a ultra-high resolution 3-dimensional optical coherence tomography.